A UK-based artificial intelligence (AI)-driven venture called Exscientia made a significant advancement involving the licensing of intellectual property in the form of an immune-modulating drug…
A mid-sized contract research organization called Worldwide Clinical Trials and a U.S.- and Swedish-based online patient matching and enrollment startup inked a deal to collaborate…
Pfizer today announced a partnership with IDA Foundation, an independent social enterprise providing essential medicines to low-and middle-income countries, to provide equitable access to quality cancer…
Germany-based CureVac, the global biopharmaceutical company developing novel transformative medicines based on messenger ribonucleic acid (“mRNA), including a high potential COVID-19 vaccine candidate, just announced…
Harvard University’s Wyss Institute for Biologically Inspired Engineering has established its first research and innovation alliance by joining forces with Northpond Labs, the research and…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
